Skip to main content

Advertisement

Ask The Doctors: J&J Booster, Pfizer For Kids

21:49
Nicholas Capote looks at the first Pfizer COVID-19 vaccine dose at Tufts Medical Center in Boston in December 2020. (Jesse Costa/WBUR)
Nicholas Capote looks at the first Pfizer COVID-19 vaccine dose at Tufts Medical Center in Boston in December 2020. (Jesse Costa/WBUR)

Those who got the Johnson and Johnson vaccine finally got a boost, so to speak, this week. The company announced that a second shot of the vaccine provides 94 percent protection against symptomatic COVID-19 infection, bringing its numbers up to Moderna or Pfizer-level protection. They have submitted the numbers to the Food and Drug Administration for booster consideration.

This after confusing messages on booster shots from the White House and then the FDA. And after Pfizer announced promising results of studies on its vaccine for children between the ages of 5 and 11.

Massachusetts announced more than 4,000 new COVID cases over the weekend, as positivity rate stays at 2 percent. With school infections, we wonder: are things getting better? Where are we on COVID?

We take listener calls with Dr. Philip Landrigan, a pediatrician, public health physician, epidemiologist, and Director of the Program for Global Public Health and the Common Good at Boston College, and Dr. Shira Doron, infectious disease physician and hospital epidemiologist at Tufts Medical Center.

This segment aired on September 21, 2021.

Headshot of Jamie Bologna
Jamie Bologna Senior Producer/Director, Radio Boston

Jamie Bologna was senior producer and director of Radio Boston.

More…
Headshot of Tiziana Dearing
Tiziana Dearing Host, Morning Edition

Tiziana Dearing is the host of WBUR's Morning Edition.

More…

Advertisement

Advertisement

Listen Live